Sukhodolsky Lab

Overview

The Sukhodolsky lab conducts research on behavioral treatments for children with autism spectrum disorder, Tourette syndrome, OCD, anxiety and disruptive behavior disorders. We investigate both how well different behavior therapies work, and how they change the brain.

We are currently studying cognitive behavioral therapy for anxiety in children with autism spectrum disorder. During this study, children receive 15 weekly sessions of CBT for anxiety and complete fMRI before and after treatment. We have also recently completed another study of cognitive behavior therapy for anger and aggression in children across diagnostic categories. Other interventions we have studied include parent training for disruptive behavior in children with autism, and behavior therapy for tics in children and adults with Tourette syndrome.

The Sukhodolsky Lab is led by Denis Sukhodolsky, PhD, Associate Professor in the Child Study Center.

Participant Eligibility/Benefits

1) We are currently recruiting children between 8 and 14 years old with AUTISM and anxiety, who are able to complete the study procedures, including fMRI.

Benefits:

  • Assessment of autism, IQ and adaptive behavior (ADOS, ADI, DAS, Vineland) free of charge to the families
  • 16 weekly sessions of CBT for anxiety free of charge to the families
  • Payment for participation up to $350
2) We are also recruiting children from 8 to 16 years, with AUTISM without anxiety and typically developing children without anxiety, who are able to complete the study including fMRI

Benefits:

  • Comprehensive assessment of autism
  • Payment for participation up to $350

Research Interest

The effectiveness and neural mechanisms of behavior therapy for neurodevelopmental disorders.

IRB Study Titles

  • Cognitive-behavior therapy (CBT) for anxiety in children with autism (HIC# 1211011144)
  • CBT for disruptive behavior in children across diagnostic categories (RDoC study; HIC# 0102012121a)
  • Behavior therapy for irritability in children with autism (HIC# 0102012121b)
  • Nicotinic cholinergic modulation as a novel treatment for aggression in autism (PI-Lewis; HIC#1502015384)

Contact Information

Study Coordinator: Tess Gladstone
Email: theresa.gladstone@yale.edu
Phone: (203) 737-7662

Principal Investigator: Denis Sukhodolsky
Email: denis.sukhodolsky@yale.edu
Phone: (203) 785-6446